Back
IDEXX Laboratories Inc (IDXX)
Health CareIDXX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$518.01
+0.95%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$13.08
ROE
72.9%
Gross margin
62.1%
Debt/Equity
0.71x
Revenue growth
14.3%
IDEXX Laboratories Inc — company intelligence
Earnings surprises
Q2 2026$4.27 vs $4.02 est+6.2%
Q1 2026$3.47 vs $3.47 est+0.1%
Q4 2025$3.08 vs $2.99 est+3.1%
Q3 2025$3.40 vs $3.19 est+6.5%
Analyst consensus · 22 analysts
14 Buy8 Hold0 Sell
Updated Oct 6, 2026
Insider activity · 90 days
1 buy1 sellnet -37 shares
Kingsley Lawrence Dother 2,203 · Sep 4, 2026
Emerson AndrewSell 86 · Aug 20, 2026
Emerson Andrewother 265 · Aug 20, 2026
Recent SEC filings
4 — Insider transaction reportSep 9, 2026
4 — Insider transaction reportAug 24, 2026
10-Q — Quarterly reportAug 4, 2026
Latest news
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets — Yahoo · 2w ago
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference — Yahoo · 2w ago
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics — Yahoo · 3w ago
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide — Yahoo · 3w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.